Blog
Drug Development
Articles filed under Drug Development, newest first.
Latest article
Why Biomarker Intelligence is Becoming Essential for Precision Drug Development
Discover why biomarker intelligence is essential for precision drug development, improving target selection, patient stratification, and clinical trial success.
Read article
Better Data for Smarter Drug Licensing Decisions
Learn how better data helps pharmaceutical companies identify the right drug licensing opportunities through clinical drug development, development of drug insights, and API drug development intelligence.
Read article
What Global Drug Pipelines Reveal About the Future of Medicine
It's the structured path a molecule follows from lab to market: preclinical research, Phase I (safety), Phase II (efficacy and dosing), Phase III (large-scale confirmation), regulatory review, and Phase IV post-market monitoring. As of 2026, nearly half of the roughly 23,000 active global pipeline drugs are still in the preclinical stage alone.
Read article
The New Era of Rare Disease Drug Development: Trends to Watch
Here is a number that should stop you: more than 10,000 rare diseases have been identified globally, yet fewer than 500 have an approved treatment.
Read article
The Rise of First in Class Drugs: What the latest clinical data
Backed by latest FDA data, this article analyzes approval trends, clinical challenges, and innovation drivers in pharmaceutical R&D.
Read articlePage 1 of 4 · 18 articles
